[ Price : $8.95]
Former FDA chief of staff Elizabeth Jungman joins law firm Hogan Lovells as a partner in its pharmaceuticals and biotechnology pra...[ Price : $8.95]
Vertex Pharmaceuticals says it will not pursue its investigational VX-993 as monotherapy for acute pain following bunionectomy sur...[ Price : $8.95]
FDA grants Dyne Therapeutics a breakthrough therapy designation for DYNE-251 for treating patients with Duchenne muscular dystroph...[ Price : $8.95]
FDA grants TransMedics Group conditional approval to begin its next-generation Organ Care System ENHANCE heart trial.[ Price : $8.95]
Philips Respironics recalls (Class 1 device correction) its V30, A30, and A40 ventilators to update their use instructions due to ...[ Price : $8.95]
Anixa Biosciences assumes full sponsorship of a Cleveland Clinic IND for ian experimental breast cancer vaccine as it heads towar...[ Price : $8.95]
A new report from STAT describes drug review turmoil at FDA that led to FDA Oncology Center of Excellence director Richard Pazdur ...[ Price : $8.95]
HHS acting general counsel Sean Keveney is appointed FDAs new chief counsel.